1. Meng, L. Y., Shi, J., & Zhou, H. L. (2009). Advances in the treatment of cervical cancer. Medical Recapitulate,
15(20), 3089–3091.
2. Du, Y., & Wu, X. (2006). The clinical application of Hedyotis diffusa. Chinese Journal of Trauma and Disability Medicine,
14(5), 93.
3. Yu, C. Y., Li, W., Liu, Y. H., et al. (2004). The study of the anti-tumor effect of Hedyotis diffusa on human cancer multiresistant Bel-7402 cells. Journal of Beihua University (Natural Science),
5(3), 221–223.
4. Shan, B. E., Zhang, J. Y., Du, X. N., et al. (2001). The immunity regulatory activity and anti-tumor effect of Hedyotis diffusa. Chinese Journal of Integrated Traditional and Western Medicine,
21(5), 370.
5. Slavesen, H. B., Lversen, O. E., & Akslen, L. A. (1999). Prognostic significance of angiogenesis and Ki-67, p53 and p21 expression: A population-based endometrial carcinoma study. Journal of Clinical Oncology,
17(5), 1382–1390.